Search

everythinglearnresearchcommunity

for

Search:↓

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Platelet-rich plasma might help treat eczema by reducing inflammation and repairing the skin.

Baricitinib effectively regrows hair in severe alopecia areata cases.

Janus kinase inhibitors effectively treat alopecia areata but may cause relapses and have long-term safety concerns.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

Blocking IL-17 can reduce skin inflammation in a mouse model of pityriasis rubra pilaris.

Skin healing from blisters can delay hair growth as stem cells focus on repairing skin over developing hair.

The research found that a specific skin cell type not only triggers hair growth but also controls hair color, and that aging can lead to hair loss and color changes.

Researchers found that the Leptin receptor is a consistent marker for hair follicle dermal cells, which may help future hair research.

PRC1 influences skin stem cell development by both turning genes on and off, affecting hair growth and skin cell types.

Sirolimus and propranolol may reduce abnormal cell growth and improve lymphatic malformations in children.

The supplement highlighted advancements and challenges in plastic and reconstructive surgery, including the impact of smoking, chemotherapy, and new treatments like Tafluprost for hair loss.

The immune system plays a key role in tissue repair, affecting both healing quality and regenerative ability.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Stem cell niches are adaptable and key for tissue maintenance and repair.

Certain microRNAs are linked to various skin diseases and could be used to diagnose and treat these conditions.

Using neurohormones to control keratin can lead to new skin disease treatments.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Minoxidil effectively treats hair loss, especially androgenetic alopecia, but needs more research for better understanding.

Leptin affects skin and hair health and may worsen some skin conditions, but more research is needed to understand its full impact.

Platelet-Rich Plasma (PRP) could potentially help regrow hair in people with Alopecia Areata, but more research is needed to confirm its effectiveness.

Sex hormones, especially estradiol, can change chicken feather shapes and colors.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Researchers identified genes and proteins that may influence wool thickness in sheep.

Cancer treatments often cause skin, nail, and hair problems.